The oncology market in India is poised for significant growth in the coming years, with a projected increase of USD 2.02 billion by 2029. The market is anticipated to expand at a CAGR of 19.8% between 2024 and 2029. As cancer cases continue to rise, driven by changing lifestyles and the increasing prevalence of tobacco and alcohol use, the demand for advanced cancer treatment and diagnostic solutions is set to soar. This growth is underpinned by a robust pipeline of research and development (R&D), technological advancements in medical devices, and an increasing focus on precision medicine.
For more details about the industry, get the PDF sample report for free
The oncology market in India is segmented into cancer treatment and cancer diagnostics. Among these, the cancer treatment segment is expected to witness substantial growth during the forecast period.
Cancer Treatment: This includes traditional treatments such as surgery, chemotherapy, and radiation therapy, as well as newer, more targeted therapies like immunotherapy, hormonal therapy, and monoclonal antibodies (mAbs). Immuno-oncology and targeted therapy are emerging as vital areas within cancer treatment. Monoclonal antibodies, such as trastuzumab, are gaining adoption for their targeted therapeutic effects, particularly in the treatment of breast cancer.
Cancer Diagnostics: Early diagnosis of cancer plays a critical role in improving survival rates. Non-invasive diagnostic tools, AI-based diagnostics, and novel approaches using gold nanoparticles are gaining attention in the Indian market. These innovations are expected to transform cancer diagnostics, making early detection more efficient and accessible.
The end-user segments in the oncology market in India include hospitals, diagnostic laboratories, diagnostic imaging centers, and others. Hospitals are the largest segment due to their capacity to handle complex cancer treatments, including surgery, chemotherapy, and radiation therapy. Diagnostic imaging centers and laboratories are crucial for the early detection of cancer, particularly in the context of growing demand for advanced diagnostic tools.
The oncology market in India is primarily focused within the country's large urban centers, with Delhi, Mumbai, Chennai, and Bangalore being major hubs for cancer treatment and diagnostics. With increasing healthcare investments, tier 2 and tier 3 cities are also witnessing growing adoption of advanced oncology treatments, reflecting the expansion of both healthcare infrastructure and access to cancer care solutions across the country.
The India oncology market is primarily driven by the rising prevalence of cancer, which is increasingly seen across various demographics due to lifestyle changes. Several key drivers are fueling market growth:
Increased Prevalence of Cancer: According to the National Cancer Registry Program of the Indian Council of Medical Research (ICMR), the estimated incidence of cancer in India rose from 14,61,427 in 2022 to 14,96,972 in 2023. This growing incidence underscores the increasing need for advanced cancer diagnostics and treatments.
Lifestyle Factors: The growing use of tobacco, alcohol, and poor dietary habits are directly contributing to the increasing incidence of cancers such as lung cancer, breast cancer, and colorectal cancer, all of which are among the leading types in India.
R&D Investment: There has been a notable increase in research and development activities, particularly in the development of AI-based diagnostic tools and theranostic therapies that combine diagnostics and treatment in one approach.
Advancements in Drug Development: The adoption of monoclonal antibodies (mAbs) and innovative therapies like immunotherapy and targeted therapies has significantly improved treatment outcomes. These developments are critical in advancing cancer care in India, especially for treating cancers like breast cancer and lymphomas.
Innovative Cancer Diagnostic Devices: In India, oncology market participants are focusing heavily on R&D for innovative diagnostic devices. AI-based diagnostic tools, coupled with non-invasive methods, are improving early-stage cancer detection. The integration of gold nanoparticles in diagnostics, which allows for both monitoring and therapeutic applications, is a promising development.
Immuno-Oncology and Targeted Therapies: The rise of immuno-oncology and personalized medicine is transforming cancer treatment in India. These therapies provide more tailored and effective treatment options, particularly for cancers like lung cancer and breast cancer, which have seen remarkable advancements in immunotherapy efficacy.
Growth in Medical Tourism: Due to the high cost of cancer treatments in developed countries, India is becoming an attractive destination for medical tourism, offering high-quality cancer care at a fraction of the cost. This trend is expected to continue growing, further boosting demand for oncology services.
AI in Treatment Personalization: AI technologies are playing a pivotal role in personalizing cancer treatments. By analyzing genetic profiles, AI can help identify the most effective therapies for individual patients, marking a shift towards more precise and targeted treatment regimens.
While the oncology market in India holds vast potential, several challenges hinder its growth:
High Treatment Costs: Despite advancements in cancer care, the cost of cancer treatments remains prohibitively high for many, especially in rural areas. The financial burden is a significant challenge, with cancer treatment often requiring multiple therapies, some of which are extremely expensive. This has driven interest in medical insurance and government initiatives aimed at making treatments more accessible.
Limited Access to Advanced Treatments in Rural Areas: Although India’s urban centers have access to advanced cancer treatments, many rural regions still lack the necessary infrastructure and expertise. This disparity in access to care is a key challenge for equitable growth in the oncology market.
Lack of Early Detection: Early cancer diagnosis is critical to improving survival rates, but many cases in India are diagnosed at later stages due to a lack of awareness and accessibility to diagnostic services. This highlights the need for continued investment in affordable and non-invasive diagnostic tools.
Get more details by ordering the complete report
The India Oncology Market has experienced significant advancements, driven by the growing demand for cancer treatment options, including chemotherapy drugs, immunotherapy cancer therapies, targeted therapy, radiation therapy, and hormone therapy. The increasing focus on early detection has spurred the use of cancer diagnostics, such as PET scans, MRI diagnostics, CT imaging, and screening kits for rapid and accurate assessments. These oncology imaging technologies play a crucial role in diagnosing and monitoring cancer, enabling more precise treatment plans. Additionally, genetic testing, biopsy procedures—including liquid biopsy—and cancer biomarkers are enhancing precision medicine in oncology, allowing for personalized care tailored to individual patient needs. As cancer screening continues to evolve, tumor markers, diagnostic tools, and pathology labs are gaining importance in identifying high-risk patients and detecting tumors at an early stage. Furthermore, oncology drugs, including newer classes like angiogenesis inhibitors and proton therapy, are contributing to a broader range of treatment options for patients across different cancer types.
These companies are not only advancing therapeutic and diagnostic solutions but also focusing on strategic alliances and expanding their presence in emerging markets, including India.
As the Indian oncology market grows, targeted therapy and immunotherapy are revolutionizing cancer treatment, offering new ways to combat metastatic cancer and drug resistance. Clinical trials in India are exploring the efficacy of novel cancer therapeutics, including monoclonal antibodies, biosimilars in oncology, and immune checkpoint therapies like CAR-T therapy. Innovative cancer vaccines, as well as hormone therapy and angiogenesis inhibitors, are making strides in enhancing the body’s immune response and blocking tumor growth. The rise of advanced oncology surgery—including robotic surgery and minimally invasive procedures—has improved patient outcomes while minimizing recovery times. Palliative care is also becoming an essential aspect of cancer treatment, especially in advanced stages. Oncology devices, radiotherapy equipment, and proton therapy systems are now integral in providing effective and accessible cancer care. The integration of oncology drugs with personalized care, cancer research, and enhanced cancer diagnostics ensures India’s oncology market continues its evolution toward better, data-driven, and compassionate care solutions.
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
